Autor(es): Belda, Walter ; Criado, Paulo Ricardo ; Passero, Luiz Felipe Domingues [UNESP]
Data: 2020
Identificador Persistente: http://hdl.handle.net/11449/201102
Origem: Oasisbr
Assunto(s): chromoblastomycosis; Fonsecaea pedrosoi; imiquimod; lesion evolution; treatment; chromoblastomycosis; chromoblastomycosis; Fonsecaea pedrosoi; Fonsecaea pedrosoi; imiquimod; imiquimod; lesion evolution; lesion evolution; treatment; treatment
Made available in DSpace on 2020-12-12T02:24:07Z (GMT). No. of bitstreams: 0 Previous issue date: 2020-04-01
Chromoblastomycosis (CBM) is a fungal infection caused by fungi belonging to the order Chaetothyriales, and caused mainly by Fonsecaea pedrosoi. The classic treatment, based on itraconazole and/or terbinafine as well as physical approaches, is considered complex and ineffective due to the high rate of relapses. Thus, new strategies are needed to manage CBM; in this regard, the present work reports the evolution of lesions in patients successfully treated with imiquimod. Of note, classic treatment was not effective in healing the lesions of two of them, but single topical treatment with imiquimod healed the lesions.
Department of Dermatology Medical School of São Paulo University (FMUSP)
Laboratory of Pathology of Infectious Diseases Medical School University of São Paulo
ABC School of Medicine Federal University of ABC
Institute of Biosciences São Paulo State University (UNESP)
Institute for Advanced Studies of Ocean São Paulo State University (UNESP)
Institute of Biosciences São Paulo State University (UNESP)
Institute for Advanced Studies of Ocean São Paulo State University (UNESP)
